Lioton

Heparin Sodium, the active ingredient in Lioton, is an anticoagulant presented as a topical preparation for skin application. It helps prevent local clot formation and is used to manage superficial thrombophlebitis, bruising, and related conditions in adults.

GNH USA supplies Lioton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lioton is a topical anticoagulant that acts on the coagulation cascade to prevent clot formation in superficial vessels. - Superficial thrombophlebitis: reduces clot formation and inflammation in affected veins. - Bruising/contusions: limits hematoma expansion and promotes faster resolution. - Skin graft donor sites: prevents clotting to improve graft take. - Peripheral IV catheter sites: decreases local thrombosis risk.

Topical application of Heparin Sodium may cause local reactions.

Common Side Effects: - Skin irritation: redness or mild discomfort at the application site. - Itching: localized pruritus. - Erythema: superficial redness. - Mild pain: transient discomfort. - Localized allergic reaction: limited rash.

Serious or Rare Side Effects: - Skin necrosis: tissue death at the site. - Severe allergic reaction: anaphylaxis requiring emergency care. - Systemic anticoagulation: unexpected bleeding. - Heparin‑induced thrombocytopenia (HIT): platelet count drop. - Extensive bruising or hematoma formation.

When using Lioton, consider the following safety measures. - Assess bleeding risk: evaluate patient history for coagulopathies. - Avoid use on infected skin: do not apply to areas with active infection. - Do not apply to open wounds unless directed: limit to intact skin. - Monitor for systemic absorption: watch for signs of unexpected bleeding. - Avoid concurrent systemic anticoagulants unless advised: coordinate with prescriber. - Store at room temperature: keep in original container, protect from moisture and light.

Heparin Sodium can interact with other agents affecting coagulation.

Major Interactions (Avoid): - Systemic anticoagulants (e.g., warfarin, DOACs): increased bleeding risk. - Thrombolytic agents (e.g., alteplase): additive anticoagulant effect. - Antiplatelet drugs (e.g., aspirin, clopidogrel) when used over large areas.

Moderate Interactions (Monitor Closely): - NSAIDs: may enhance bleeding tendency. - Topical corticosteroids: may affect skin integrity. - Herbal supplements with anticoagulant properties (e.g., ginkgo, garlic).